Research & Development



  過了半晌,他揉揉發澀的眼楮,確定自己不是在做夢。   “謝謝。”陸昔年很感動,他一直對陳海隱瞞了自己的性向,沒想到對方不但沒生他的氣,還挺身而出維護他。免费手机在线观看视频   此時此刻,這只在網絡上蹦噠的臭蟲,並不能影響陸昔年的美好心情。超碰公开   過于悲憤的表情引起了室友的注意。   苦逼的學醫生涯!超碰最新   “草莓特別甜。”年年也是。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo